BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2684591)

  • 1. Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders.
    Todd PA; Benfield P
    Drugs; 1989 Oct; 38(4):481-99. PubMed ID: 2684591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.
    Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Jan; 27(1):6-44. PubMed ID: 6141044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine.
    Verspeelt J; De Locht P; Amery WK
    Eur J Clin Pharmacol; 1996; 51(1):15-22. PubMed ID: 8880046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flunarizine and betahistine. Two different therapeutic approaches in vertigo compared in a double-blind study.
    Elbaz P
    Acta Otolaryngol Suppl; 1988; 460():143-8. PubMed ID: 3074614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flunarizine in migraine prophylaxis: the clinical experience.
    Schmidt R; Oestreich W
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S21-6. PubMed ID: 1726732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flunarizine-pizotifen single-dose double-blind cross-over trial in migraine prophylaxis.
    Cerbo R; Casacchia M; Formisano R; Feliciani M; Cusimano G; Buzzi MG; Agnoli A
    Cephalalgia; 1986 Mar; 6(1):15-8. PubMed ID: 3516406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term efficacy and side effects of various migraine prophylactics: a retrospective analysis.].
    Haag G; Mastrosimone F; Iaccarino C; Müller MJ
    Schmerz; 1994 Sep; 8(3):162-9. PubMed ID: 18415473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A postmarketing study of flunarizine in migraine and vertigo.
    de Bock GH; Eelhart J; van Marwijk HW; Tromp TP; Springer MP
    Pharm World Sci; 1997 Dec; 19(6):269-74. PubMed ID: 9443168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine.
    Nappi G; Sandrini G; Savoini G; Cavallini A; de Rysky C; Micieli G
    Drugs; 1987; 33 Suppl 2():103-9. PubMed ID: 3304950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial.
    Lepcha A; Amalanathan S; Augustine AM; Tyagi AK; Balraj A
    Eur Arch Otorhinolaryngol; 2014 Nov; 271(11):2931-6. PubMed ID: 24166742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-channel blockers in the treatment of migraine.
    Gelmers HJ
    Am J Cardiol; 1985 Jan; 55(3):139B-143B. PubMed ID: 3881906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium entry blockers in the treatment of vertigo.
    Olesen J
    Ann N Y Acad Sci; 1988; 522():690-7. PubMed ID: 3377379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.
    Gawel MJ; Kreeft J; Nelson RF; Simard D; Arnott WS
    Can J Neurol Sci; 1992 Aug; 19(3):340-5. PubMed ID: 1393843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists in migraine and vertigo. Possible mechanisms of action and review of clinical trials.
    Olesen J
    Eur Neurol; 1990; 30 Suppl 2():31-4; discussion 39-41. PubMed ID: 2180716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Flunarizine in the prophylaxis of vestibular migraine:a randomized controlled trial].
    Yuan Q; Liu DL; Yu LS; Zhang QF
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(10):805-810. PubMed ID: 29798059
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind placebo-controlled evaluation of flunarizine as adjunct therapy in epilepsy with complex partial seizures.
    Alving J; Kristensen O; Tsiropoulos I; Mondrup K
    Acta Neurol Scand; 1989 Feb; 79(2):128-32. PubMed ID: 2496577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of flunarizine (Sibelium) and pizotifen (Sandomigran) in migraine treatment: a double-blind study.
    Louis P; Spierings EL
    Cephalalgia; 1982 Dec; 2(4):197-203. PubMed ID: 6760980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Double-blind clinical study: flunarizine versus pizotifen in a single nightly dose in hemicrania patients].
    Cerbo R; Casacchia M; Formisano R; Buzzi MG; Boni B; Feliciani M; Grillo G; Cusimano G; Agnoli A
    Riv Neurol; 1985; 55(2):139-46. PubMed ID: 4012191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flunarizine in migraine: a minireview.
    Leone M; Grazzi L; La Mantia L; Bussone G
    Headache; 1991 Jun; 31(6):388-91. PubMed ID: 1889980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of migraine using flunarizine (results of a pilot study using Amalium)].
    Wessely P; Holzner F
    Wien Med Wochenschr; 1987 Jan; 137(1):21-6. PubMed ID: 3590812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.